| Name | Lane House, The |
|---|---|
| Location | 1000 Lane Ave, Crawfordsville, Indiana |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 49.17% |
| Medicare ID (CCN) | 155477 |
| Legal Business Name | Hendricks County Hospital |
| Ownership Type | Government - County |
| NPI Number | 1669428496 |
| Organization Name | HENDRICKS COUNTY HOSPITAL |
| Doing Business As | THE LANE HOUSE |
| Address | 1000 Lane Avenue, Crawfordsville, IN 47933 |
| Phone Number | 765-362-0007 |
News Archive
Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
Nine new alluring, body-contouring and eco-friendly tanning beds make up a new line of commercial tanning beds that begin shipping soon from tanning equipment leader ETS Tan.
The U.S. Food and Drug Administration today advised consumers not to use certain respiratory medications purchased after Sept. 8, 2009 and manufactured by Dey L.P., a subsidiary of Mylan Inc., because the medications might have been part of a shipment being transported on a tractor-trailer stolen in Tampa, Fla., on Sept. 8, 2009.
As advances in medicine are giving rise to growing numbers of children who are surviving severe heart defects, a phenomenon is emerging that is catching parents and healthcare providers off-guard. Over half of these children also have a seemingly unrelated disability: neurodevelopmental disorders. Some have severe cognitive and motor deficits that arise early.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
Nine new alluring, body-contouring and eco-friendly tanning beds make up a new line of commercial tanning beds that begin shipping soon from tanning equipment leader ETS Tan.
The U.S. Food and Drug Administration today advised consumers not to use certain respiratory medications purchased after Sept. 8, 2009 and manufactured by Dey L.P., a subsidiary of Mylan Inc., because the medications might have been part of a shipment being transported on a tractor-trailer stolen in Tampa, Fla., on Sept. 8, 2009.
As advances in medicine are giving rise to growing numbers of children who are surviving severe heart defects, a phenomenon is emerging that is catching parents and healthcare providers off-guard. Over half of these children also have a seemingly unrelated disability: neurodevelopmental disorders. Some have severe cognitive and motor deficits that arise early.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $9750 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20.75 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 14.88 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 55.56 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.26 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.49 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.91 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.67 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.04 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 82.05 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 32.44 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 25.16 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.67 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.37 | 95.98 |